Drugs Made In America Acquisition LLC

CIK: 0002038492

Transaction Breakdown

Open Market Buys (P)2 (50.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DMAA

Drugs Made In America Acquisition Corp.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (4 total)

DMAA
Drugs Made In America Acquisition Corp.
Feb 18, 2025
Purchase(P)
Direct
30K shares-
DMAA
Drugs Made In America Acquisition Corp.
Jan 29, 2025
Purchase(P)
Direct
400K shares-
DMAA
Drugs Made In America Acquisition Corp.
Jan 29, 2025
Other(J)
Direct
400K shares-
DMAA
Drugs Made In America Acquisition Corp.
Jan 29, 2025
Sale(S)
Direct
5.7M shares-

		Type	Shares	Price		Ownership
Feb 18, 2025	DMAA Drugs Made In America Acquisition Corp.	Purchase(P)	30,000	-	-	Direct
Jan 29, 2025	DMAA Drugs Made In America Acquisition Corp.	Purchase(P)	400,000	-	-	Direct
Jan 29, 2025	DMAA Drugs Made In America Acquisition Corp.	Other(J)	400,000	-	-	Direct
Jan 29, 2025	DMAA Drugs Made In America Acquisition Corp.	Sale(S)	5,698,363	-	-	Direct

1-4 of 4 transactions

About Drugs Made In America Acquisition LLC

Drugs Made In America Acquisition LLC (SEC CIK 0002038492) files insider reports with the SEC as 10% Owner of Drugs Made In America Acquisition Corp. (DMAA).

Signal8 holds 3 ownership filings by Drugs Made In America Acquisition LLC (1 Form 3, 2 Form 4), filed between Jan 10, 2025 and Feb 18, 2025. Those filings report 4 transactions, from Jan 29, 2025 to Feb 18, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Drugs Made In America Acquisition LLC's filings is in FORT LAUDERDALE, FL.

Recent filings by Drugs Made In America Acquisition LLC

Feb 18, 2025: Open-market purchase of DMAA shares (Form 4, code P).
Jan 29, 2025: Open-market purchase of DMAA shares (Form 4, code P).
Jan 29, 2025: Other transaction of DMAA shares (Form 4, code J).
Jan 29, 2025: Open-market sale of DMAA shares (Form 4, code S).

Other insiders filing for Drugs Made In America Acquisition Corp. (DMAA)

Stockwell Lynn, CEO and Executive COB
Shulgan Myron W., Director
Prasad Sridhar G., Director
Do Catherine, Director
Worman Glenn C., CFO

How to read Form 4 transaction codes